{"symbol":"BSX","fiscalQuarter":"Q3-2017","reportDate":"2017-10-26","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2017","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Down 2.67%","keyNumbers":[{"metric":"EPS","actual":"$0.31","expected":"N/A","surprise":"-0.31%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted ongoing challenges in the market.","They emphasized a focus on operational efficiency.","Future growth strategies were discussed but lacked specifics."],"summary":"Management expressed concerns about current market conditions impacting performance. They highlighted efforts to improve efficiency but did not provide detailed future plans."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"The earnings report indicates that Boston Scientific faced challenges that impacted its earnings per share, resulting in a stock decline of 2.67%. Investors may be concerned about the lack of guidance and management's cautious tone regarding market conditions. This could lead to increased scrutiny in the coming quarters as the company navigates these challenges.","metaDescription":"Boston Scientific (BSX) Q3 2017 earnings: EPS missed. Stock down 2.67%. Full breakdown."}}